Should You Get Retested After STD Treatment? When and Why Repeat Testing Matters

Key takeaways

• There is no single retesting schedule for every sexually transmitted infection.
• For chlamydia and gonorrhea, retesting at approximately 3 months generally checks for repeat infection rather than automatically proving treatment failure.
• A test of cure may be appropriate in specific situations, including pregnancy with chlamydia and pharyngeal gonorrhea.
• Sexually active women treated for trichomoniasis should be retested at approximately 3 months; evidence is insufficient for routine retesting of men.
• Syphilis requires infection-stage-specific clinical and serologic follow-up, not simply one routine retest.
• Persistent or recurrent symptoms, uncertain adherence, or possible re-exposure should be discussed with a healthcare professional.

Yes, many people should be retested after treatment for an STD, but the timing and purpose of testing depend on the infection and your circumstances. Retesting after treatment is often intended to detect a repeat infection, while a test of cure is used in selected situations to evaluate whether an infection has cleared. These are not the same thing, and a routine retest at about three months does not automatically mean that the original treatment failed.

Retesting versus a test of cure

Routine retesting is usually scheduled after treatment to look for repeat infection. Repeat positive results can occur because a partner was not treated, because of a new infected partner, or because of another exposure. A test of cure is a clinician-directed check performed sooner or under specific circumstances to assess whether infection is still present. The right approach can depend on the infection, treatment regimen, pregnancy status, infection site, symptoms, adherence, HIV status, and possible re-exposure.

Testing too soon can sometimes be misleading. For some infections, a nucleic acid amplification test, or NAAT, may detect residual nucleic acid after treatment rather than indicate an active infection. That is why the timing of any follow-up test should match the infection-specific guidance and the reason for testing.

When to retest after common bacterial STIs

Why reinfection can happen after successful treatment

Treatment can address an infection that was present at the time of diagnosis, but it does not provide lasting protection from a future exposure. A repeat positive result may reflect reinfection rather than failure of the original treatment. Untreated or newly infected partners can be one reason repeat infection occurs. Because partner evaluation and treatment can be important parts of preventing repeat infection, ask a healthcare professional what steps are appropriate for your situation.

A scheduled retest is also useful when symptoms have improved or disappeared, because symptoms alone cannot establish whether an infection is absent. Conversely, a positive result does not by itself explain whether the cause is reinfection, persistence, or another issue. Interpretation requires the test type, timing, exposure history, treatment history, and clinical context.

Special situations that can change the timeline

What if you test too soon?

The meaning of an early result depends on the infection and the test used. For chlamydia, NAAT testing before 4 weeks after treatment can be misleading. For recurrent or persistent trichomoniasis, CDC guidance says NAAT evaluation should not occur before 3 weeks after treatment completion because residual nucleic acid can produce a clinically misleading positive result. These timing limits are reasons to follow infection-specific guidance instead of using one waiting period for every STI.

A simple follow-up checklist

The bottom line

Retesting after STD treatment is often important, but there is no universal schedule. Approximately 3-month retesting is recommended after treatment for chlamydia and gonorrhea and for sexually active women treated for trichomoniasis. Pregnancy, pharyngeal gonorrhea, persistent symptoms, uncertain adherence, possible re-exposure, and syphilis require more specific follow-up. A clinician can help determine whether you need routine rescreening, a test of cure, or additional evaluation.

For broader information about choosing a testing approach, visit our sexual health testing guides or review the available testing options. Medical guidance should take priority when you have symptoms, are pregnant, or have concerns about treatment response.